Get the Stockscreener App
6.1756
0.10%
-0.0062
Bioharvest Sciences Inc stock is traded at $6.1756, with a volume of 5,637.
It is down -0.10% in the last 24 hours and up +0.00% over the past month.
See More
Previous Close:
$6.1818
Open:
$6.5
24h Volume:
5,637
Relative Volume:
2.32
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-4.25%
1M Performance:
+0.00%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$6.0001
$6.50
1-Week Range:
$5.945
$6.50
52-Week Range:
$5.85
$6.72
Bioharvest Sciences Inc Stock (BHST) Company Profile
Name
Bioharvest Sciences Inc
Sector
Industry
Phone
-
Address
-
Compare BHST with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BHST
Bioharvest Sciences Inc
|
6.1756 | 0 | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
464.56 | 119.70B | 10.63B | -479.80M | -1.35B | 13.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
754.87 | 82.75B | 13.85B | 4.65B | 3.32B | 35.06 |
|
ARGX
Argen X Se Adr
|
614.59 | 36.73B | 1.86B | -40.29M | -1.28B | -4.16 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
253.74 | 32.53B | 2.09B | -332.26M | 16.06M | -4.14 |
|
BNTX
Biontech Se Adr
|
120.72 | 28.50B | 3.30B | -501.07M | 1.03B | 11.54 |
Bioharvest Sciences Inc Stock (BHST) Latest News
BioHarvest Sciences expands VINIA product line with launch of SuperFood Infused Teas - Proactive Investors
BioHarvest Sciences Inc (CNVCF) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ... - Yahoo Finance
BioHarvest reports strong response from VINIA Superfood Coffee - Comunicaffe
BioHarvest Launches VINIA SuperFood Functional Tea Line - Sault This Week
BioHarvest Sciences Inc. (BHST) Reports Q3 Loss, Misses Revenue Estimates - MSN
BioHarvest Sciences Surpasses Q3 Revenue Expectations - TipRanks
Q3 2024 Bioharvest Sciences Inc Earnings Call Transcript - GuruFocus.com
BioHarvest Sciences Doubles Revenue, Reports 101% Growth in Q3 2024 Earnings | BHST Stock News - StockTitan
Bioharvest Sciences Inc (BHSC-CN) QuotePress Release - The Globe and Mail
BioHarvest Sciences reports increased revenues, profits for Q3 - Proactive Investors USA
BioHarvest Sciences launches VINIA SuperFood Teas - Proactive Investors USA
BioHarvest Sciences Launches VINIA SuperFood Teas - TipRanks
Bioharvest Sciences Inc (BHST-Q) QuotePress Release - The Globe and Mail
CNVCF (BioHarvest Sciences) 3-Year Dividend Growth Rate : 0.00% (As of Jun. 2024) - GuruFocus.com
CNVCF (BioHarvest Sciences) Total Inventories : $2.57 Mil (As of Jun. 2024) - GuruFocus.com
BioHarvest Sciences Engages Investors at Upcoming Conference - TipRanks
BioHarvest Sciences to Participate in Noble Capital Markets Emerging Growth Conference on December 3, 2024 - Newsfile
CNVCF (BioHarvest Sciences) GF Value Rank : 2 (As of Nov. 21, 2024) - GuruFocus.com
Ilan Sobel, CEO of BioHarvest Sciences - iHeart
BioHarvest Sciences to Announce Q3 2024 Results - TipRanks
BioHarvest Sciences announces third quarter earnings date - Proactive Investors UK
BioHarvest Sciences to Host Third Quarter 2024 Earnings Call on November 25 at 4:30 P.M. Eastern Time - The Kingston Whig-Standard
BioHarvest Sciences Sets Q3 2024 Earnings Call for November 25 | BHST Stock News - StockTitan
Revenues Tell The Story For BioHarvest Sciences Inc. (CSE:BHSC) As Its Stock Soars 26% - Simply Wall St
BioHarvest shares rise in Nasdaq debut - Proactive Investors USA
BioHarvest Sciences Begins Nasdaq Trading - TipRanks
BioHarvest Sciences Begins Trading on the Nasdaq Global Market - Newsfile
BioHarvest Sciences Uplists to Nasdaq, Expanding Shareholder Base - TipRanks
Canada Market’s top losers: Enterprise Group-14.16%, BioHarvest Sciences -12.34% - Business Upturn
BioHarvest Sciences shares to list on Nasdaq next week - Proactive Investors Australia
BioHarvest Sciences Announces Uplisting to the Nasdaq Global Market - StockTitan
BioHarvest Sciences set to begin trading on Nasdaq, marking major milestone in U.S. market expansion - Proactive Investors USA
BioHarvest Sciences appoints new CFO - Proactive Investors USA
BioHarvest Sciences expects record third quarter revenue as it nears Nasdaq uplisting | CSE:BHSC, OTC:CNVCF - Proactive Investors USA
BioHarvest Sciences to Participate in LD Micro Main Event XVII Conference on October 30, 2024 - Yahoo Finance
BioHarvest Sciences reshuffles board amid Nasdaq listing efforts - Proactive Investors USA
BioHarvest Sciences to Participate in iAccess Alpha Buyside Best Ideas Conference on September 24-25, 2024 - Newsfile
BioHarvest Sciences to Showcase at Global Investment Conference - TipRanks
BioHarvest Sciences Second Quarter 2024 Earnings: US$0.042 loss per share (vs US$0.21 loss in 2Q 2023) - Simply Wall St
BioHarvest Sciences Reports Record Second Quarter 2024 Financial Results - BioSpace
BioHarvest Sciences Surpasses USD $1.0 Million in Cumulative Direct Sales of Coffee with VINIA Inside - Yahoo Finance
BioHarvest Sciences closes first tranche of private placement - Proactive Investors UK
BioHarvest Sciences Announces a Private Placement of up to USD $5 Million and Conversion of Debt Notes - Yahoo Finance
BioHarvest Sciences Announces Record $2 Million Monthly Sales - Yahoo Finance
BioHarvest Sciences Reports First Quarter 2024 Financial Results - StockTitan
BioHarvest Sciences Announces New Strategic Hires for CDMO Services Business Unit - BioSpace
BioHarvest Sciences launches contract development and manufacturing organization business unit - Proactive Investors UK
BioHarvest Sciences to Present at the 2024 BIO CEO & Investor Conference By Investing.com - Investing.com Canada
BioHarvest Issues 2023 Year End Shareholder Letter and Provides Corporate Update - Financial Content
BioHarvest Sciences Inc. Closes Final Tranche of Oversubscribed $13.5M Private Placement - StockTitan
BioHarvest Sciences Announces Major Product Launch of VINIA-Based Functional Coffees - Nasdaq
Bioharvest Sciences Inc Stock (BHST) Financials Data
There is no financial data for Bioharvest Sciences Inc (BHST). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
1.35%
0.87%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):